Tifany sells OGXI 3.5: OncoGenex Pharmaceuticals Announces Pricing of $24 Million Underwritten Registered Direct Offering
BOTHELL, Wash. and VANCOUVER, British Columbia, June 26, 2014 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) today announced that it has priced an underwritten registered direct offering, which is expected to raise gross proceeds of $24 mill ... ...
22 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home